Fluticasone propionate 100 mcg/blister oral inhalation powder/Respirent Pharmaceuticals

DRUG2 trials

Sponsors

Respirent Pharmaceuticals Co Ltd.

Conditions

AsthmaBioequivalence

Phase 1

A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions

Respirent Pharmaceuticals Co Ltd.Asthma, Bioequivalence

Start: 2021-08-13End: 2021-11-30Target: 50Updated: 2021-08-26

Phase 3

A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma

CompletedNCT04665895

Respirent Pharmaceuticals Co Ltd.Asthma

Start: 2020-12-09End: 2022-02-22Updated: 2023-04-06